CD22 blockade exacerbates neuroinflammation in Neuromyelitis optica spectrum disorder
Wenjun Zhang,Yali Han,Huachen Huang,Yue Su,Honglei Ren,Caiyun Qi,Jinyi Li,Huaijin Yang,Jing Xu,Guoqiang Chang,Wenjin Qiu,Qiang Liu,Ting Chang
DOI: https://doi.org/10.1186/s12974-024-03305-2
IF: 9.3
2024-12-03
Journal of Neuroinflammation
Abstract:Neuromyelitis optica spectrum disorder (NMOSD) is an autoantibody-triggered central nervous system (CNS) demyelinating disease that primarily affects the spinal cord, optic nerves and brainstem. Among the first responders to CNS injury, microglia are prominent players that drive NMOSD lesion formation. However, the key molecular switches controlling the detrimental activity of microglia in NMOSD are poorly understood. CD22 governs the activity of innate and adaptive immunity. In this study, we investigated to what extent and by what mechanisms CD22 may modulate microglial activity, neuroinflammation and CNS lesion formation.
immunology,neurosciences
What problem does this paper attempt to address?